Bottom line
BBH vs IBBQ: the short answer
BBH (VanEck Biotech ETF) and IBBQ (Invesco Nasdaq Biotechnology ETF) share a meaningful slice of their top holdings — about 59% by weight.
But IBBQ is far broader, holding 261 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
IBBQ is cheaper at 0.19% vs 0.35% — a difference of $16 a year per $10,000 invested.
Over one year, BBH returned +21.2% vs −0.6% for IBBQ (reporting dates differ).
Updated Nov 19, 2026
BBH vs IBBQ side by side
| BBH | IBBQ | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | VanEck | Invesco |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.35% | 0.19% |
| Annual cost per $10k | $35 | $19 |
| 10-yr cost on $10k (prospectus) | $443 | $242 |
| Max front load | None | None |
| 12b-1 fee | — | — |
| 1-yr return | +21.2% | −0.6% |
| 5-yr return (annualized) | +2.7% | — |
| 10-yr return (annualized) | +4.5% | — |
| Best quarter | +27.6% | +12.0% |
| Worst quarter | −18.2% | −11.7% |
| Net assets (fund) | $395.6M | $67.4M |
| Number of holdings | 25 | 261 |
| Portfolio turnover | 19% | 17% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BBH | IBBQ | Difference |
|---|---|---|---|
| 2024 | −4.4% | −0.6% | −3.8% |
| 2023 | +3.9% | +4.5% | −0.6% |
| 2022 | −15.1% | −10.2% | −4.9% |
Source: Fund prospectus bar charts
Holdings overlap
14 of BBH's top 25 holdings also appear in IBBQ's top 25.
| Holding | BBH | IBBQ |
|---|---|---|
| Amgen Inc | 15.25% | 7.10% |
| Gilead Sciences Inc | 12.79% | 7.39% |
| Vertex Pharmaceuticals Inc | 9.10% | 7.38% |
| Regeneron Pharmaceuticals Inc | 6.21% | 5.08% |
| Revolution Medicines Inc | 5.27% | 2.48% |
| Argenx SE | 4.97% | 1.89% |
| Alnylam Pharmaceuticals Inc | 3.83% | 3.19% |
| Biogen Inc | 3.63% | 2.29% |
| Moderna Inc | 3.36% | 1.48% |
| Illumina Inc | 3.17% | 1.98% |
| United Therapeutics Corp | 2.83% | 1.94% |
| Insmed Inc | 2.67% | 1.83% |
| Incyte Corp | 2.49% | 1.53% |
| Neurocrine Biosciences Inc | 2.08% | 1.26% |
Source: SEC Form N-PORT
BBH top 10
- Amgen Inc — 15.25%
- Gilead Sciences Inc — 12.79%
- Vertex Pharmaceuticals Inc — 9.10%
- Regeneron Pharmaceuticals Inc — 6.21%
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
IBBQ top 10
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Vertex Pharmaceuticals Inc. — 7.38%
- Amgen Inc. — 7.10%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Revolution Medicines, Inc. — 2.48%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
FAQ
What is the difference between BBH and IBBQ?
Which is cheaper, BBH or IBBQ?
Should I own both BBH and IBBQ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.